12.09.2016 • NewsBrenntagElaine BurridgeLubricants

Brenntag Buys US Lubricants Business

(c) Brenntag
(c) Brenntag

German-based global chemical distributor Brenntag has once again boosted its presence in the North American lubricants market with the purchase of Mayes County Petroleum Products (MCP), which is headquartered in Pryor, Oklahoma, USA. The deal follows two other acquisitions made in the US last December, notably J.A.M. Distributing Company, headquartered in Houston, Texas, and G.H. Berlin-Windward, headquartered in Manchester, New Hampshire.

MCP distributes lubricants, commercial fuel, chemicals and ancillary services to customers in the industrial, commercial, construction, mining and agricultural markets, mainly throughout Oklahoma. The business posted sales of $37 million in 2015. Markus Klähn, CEO of Brenntag North America, said the company intends to take an active and regionally selective part in consolidating the North American lubricants distribution sector which is highly attractive and still fragmented.

The transaction is expected to close over the course of the coming weeks. Financial details were not disclosed.

Company

Logo:

Brenntag SE

Messeallee 11
45131 Essen
Netherlands

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.